Saturday, 13 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Prof. Dr. med. Volker Heinemann: Comments on FIRE-3 & CALGB/SWOG 80405

Prof. Dr. med. Volker Heinemann: Comments on FIRE-3 & CALGB/SWOG 80405У вашего броузера проблема в совместимости с HTML5
Interview with Prof. Dr. med. Volker Heinemann, Klinikum der Universität München, Klinikum Großhadern, München, Germany Comments on FIRE-3 & CALGB/SWOG 80405
Опубликовано: 29-09-2014
Теги: oncoletter ESMO 2014 ESMO Thomas Ferber FIRE-3 CALGB/SWOG 80405 Cetuximab Bevacizumab (Drug)

Похожие видео
Prof. Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli

Prof. Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli08:15

Jeffrey A. Meyerhardt, MD discusses the phase 3 CALGB/SWOG 80405 study

Jeffrey A. Meyerhardt, MD discusses the phase 3 CALGB/SWOG 80405 study00:53

Volker Heinemann, University of Munich, Munich, Germany

Volker Heinemann, University of Munich, Munich, Germany06:14

Prof. Gerit Heinemann - Web excellence

Prof. Gerit Heinemann - Web excellence51:40

Мой аккаунт

Вход / Log In